Palisade Asset Management’s DexCom DXCM Stock Holding History

Palisade Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,200	Closed	-$80.7K	–	329
2025 Q3	$80.7K	Buy	+1,200	New	+$95K	0.01%	246
2024 Q2	–	Sell	-1,234	Closed	-$171K	–	250
2024 Q1	$171K	Buy	+1,234	New	+$155K	0.02%	204
2022 Q3	–	Sell	-2,756	Closed	-$205K	–	175
2022 Q2	$205K	Hold	2,756	–	–	0.03%	174
2022 Q1	$352K	Hold	2,756	–	–	0.04%	161
2021 Q4	$370K	Hold	2,756	–	–	0.04%	158
2021 Q3	$377K	Sell	2,756 -180	-6%	-$22.7K	0.05%	157
2021 Q2	$313K	Sell	2,936 -1,200	-29%	-$115K	0.04%	162
2021 Q1	$372K	Sell	4,136 -1,600	-28%	-$150K	0.05%	153
2020 Q4	$530K	Sell	5,736 -164	-3%	-$14.6K	0.07%	137
2020 Q3	$608K	Hold	5,900	–	–	0.09%	118
2020 Q2	$598K	Hold	5,900	–	–	0.1%	118
2020 Q1	$397K	Buy	+5,900	New	+$367K	0.07%	133

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Palisade Asset Management's DXCM Position: Q4 2025 in Review

Palisade Asset Management sold out of DexCom (DXCM) in Q4 2025, closing a stake of 1,200 shares — an estimated $80.7K sold.

Palisade Asset Management first reported a position in DXCM in Q1 2020 and held it in 12 quarters. The position peaked at $608K in Q3 2020. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

Palisade Asset Management reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
Palisade Asset Management sold 1,200 DexCom shares in Q4 2025, an estimated $80.7K.
Palisade Asset Management first reported a position in DexCom in Q1 2020 and held it in 12 quarters.
Palisade Asset Management's DexCom position peaked at $608K in Q3 2020.
922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Palisade Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.